Peptide lysates were injected on a trapping column (Acclaim PepMap 100 C18, 3 m, nanoViper, 75 m x 2 cm, Thermo Fisher Scientific) with 5 L/min by using 98% water/2% ACN 0.5% trifluoroacetic acid, and separated on an analytical column (Acclaim PepMap 100 C18, 3 m, nanoViper, 75 m x 25 cm, Thermo Fisher Scientific) with a flow rate of 300 nL/min
The label heavily restricts compounding pharmacies from making it
The decisive evidence controlled human trials with counted hair as the endpoint does not robustly exist for GHK-Cu monotherapy
Two thymosins are commonly used in peptide therapy: thymosin alpha 1 ( T1 ) and thymosin beta 4 (T4), as described in the following sections
Both have value
It minimizes the chance of calculation errors during the actual administration phase of a study